Skip to content

Released Aug 8, 2013

10-Q filed Aug 8, 2013, 39 days after period end · 0001104659-13-061714

Q2 2013 · 10-Q
Revenue$9.66M−33.8% vs Q2 2012+196.9% vs Q1 2013
Net income—
EPS Diluted-$0.57N/M vs Q2 2012N/M vs Q1 2013
Operating Income-$59,880,000N/M
Operating Cash Flowderived-$80,140,000N/M
Free Cash Flowderived-$82,094,000N/M
Margins · derived
Operating margin-619.7%−340.1 pt vs Q2 2012

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2013Q2 2012Q2 2011Q2 2010
Revenue$9.66M$14.60M$11.26M$9.19M
Net Income——-$18.84M-$17.14M
EPS Diluted-$0.57-$0.38-$0.19-$0.18

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR